Bolte Axel
Insider CIK 1579247 · PTCT Director · OPHT Director · ALNA Director · INZY See Remarks, Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INZY Inozyme Pharma, Inc. | D To issuer deriv | 2025-07-01 | 2025-07-03 | 234,176 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | D To issuer deriv | 2025-07-01 | 2025-07-03 | 159,187 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | U Tender | 2025-07-01 | 2025-07-03 | 423,926 | $4.00 | $1.70M | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | M Exercise deriv | 2025-05-15 | 2025-05-20 | 152,823 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | M Exercise deriv | 2025-05-15 | 2025-05-20 | 4,407 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | M Exercise | 2025-05-15 | 2025-05-20 | 152,823 | $0.98 | $149.8K | 419,519 | SEC↗ |
| INZY Inozyme Pharma, Inc. | M Exercise | 2025-05-15 | 2025-05-20 | 4,407 | $0.98 | $4.3K | 423,926 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2024-06-18 | 2024-06-20 | 28,000 | — | $0 | 28,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 16,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 15,500 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 16,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 23,186 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 16,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 16,000 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer deriv | 2023-07-11 | 2023-07-13 | 7,500 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | D To issuer | 2023-07-11 | 2023-07-13 | 22,088 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2023-06-13 | 2023-06-15 | 16,000 | — | $0 | 16,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2023-05-17 | 2023-05-19 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2023-05-11 | 2023-05-15 | 14,588 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2023-05-11 | 2023-05-15 | 14,588 | — | $0 | 22,088 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2023-05-01 | 2023-05-03 | 100,000 | — | $0 | 100,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award | 2023-03-31 | 2023-04-04 | 4,806 | $2.21 | $10.6K | 266,696 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award | 2022-09-30 | 2022-10-04 | 3,315 | $2.28 | $7.6K | 261,890 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2022-05-12 | 2022-05-13 | 14,588 | — | $0 | 14,588 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2022-05-12 | 2022-05-13 | 23,186 | — | $0 | 23,186 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise deriv | 2022-05-11 | 2022-05-13 | 7,500 | — | $0 | 0 | SEC↗ |
| ISEE IVERIC bio, Inc. | M Exercise | 2022-05-11 | 2022-05-13 | 7,500 | — | $0 | 7,500 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2022-04-19 | 2022-04-20 | 67,750 | $3.69 | $250.0K | 258,575 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2022-02-24 | 2022-02-28 | 275,000 | — | $0 | 275,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | M Exercise deriv | 2021-06-24 | 2021-06-25 | 66,788 | — | $0 | 100,480 | SEC↗ |
| INZY Inozyme Pharma, Inc. | S Sale | 2021-06-24 | 2021-06-25 | 66,788 | — | $0 | 190,825 | SEC↗ |
| INZY Inozyme Pharma, Inc. | M Exercise | 2021-06-24 | 2021-06-25 | 66,788 | $0.98 | $65.5K | 257,613 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2021-05-19 | 2021-05-20 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2021-05-19 | 2021-05-20 | 15,500 | — | $0 | 15,500 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2021-03-04 | 2021-03-17 | 117,000 | — | $0 | 117,000 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2021-01-13 | 2021-01-14 | 159,187 | — | $0 | 159,187 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2021-01-13 | 2021-01-14 | 66,788 | — | $0 | 66,788 | SEC↗ |
| INZY Inozyme Pharma, Inc. | A Award deriv | 2020-07-23 | 2020-07-24 | 287,706 | — | $0 | 287,706 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 16,000 | — | $0 | 16,000 | SEC↗ |
| ISEE IVERIC bio, Inc. | A Award deriv | 2019-05-15 | 2019-05-16 | 16,000 | — | $0 | 16,000 | SEC↗ |
| ALNA Allena Pharmaceuticals, In | A Award deriv | 2018-06-08 | 2018-06-12 | 10,182 | — | $0 | 10,182 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2018-05-23 | 2018-07-11 | 16,000 | — | $0 | 16,000 | SEC↗ |
| OPHT Ophthotech Corp. | A Award deriv | 2017-05-19 | 2017-05-22 | 16,000 | — | $0 | 16,000 | SEC↗ |
| OPHT Ophthotech Corp. | S Sale | 2016-12-30 | 2017-01-23 | 6,000 | $4.83 | $29.0K | 0 | SEC↗ |
| OPHT Ophthotech Corp. | P Buy | 2016-06-03 | 2016-06-07 | 3,500 | $56.97 | $199.4K | 6,000 | SEC↗ |
| OPHT Ophthotech Corp. | P Buy | 2015-03-30 | 2015-04-01 | 500 | $48.27 | $24.1K | 2,500 | SEC↗ |
| OPHT Ophthotech Corp. | P Buy | 2013-09-25 | 2013-10-07 | 2,000 | $22.00 | $44.0K | 2,000 | SEC↗ |
| PTCT PTC THERAPEUTICS, INC. | P Buy | 2013-06-25 | 2013-06-27 | 20,000 | $15.00 | $300.0K | 20,000 | SEC↗ |